AIR COMPRESSOR NEBULIZER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Developments

• In May 2024, Medline, a healthcare company, introduced the Hudson RCI TurboMist small-volume nebulizer, which delivers medication in just three minutes, significantly faster than traditional nebulizers that take around 10 minutes. TurboMist administers medication 2.5 times more quickly per minute than standard nebulizers, providing nearly 70% faster treatment.
• In June 2022 UNICEF the United Nations International Children's Emergency Fund, acquired and transported 160 superior nebulizers to Iran at the request of the Ministry of Health and Medical Education of Iran. The fund was made possible by donations from Tejarat Bank, Saman Bank, and Edge Business Group. Children with cystic fibrosis (CF), a genetic illness predominantly affecting the lungs that causes mucus buildup and causes breathing difficulties and recurrent infections, are the target audience for these nebulizers.
• In May 2023 PARI, a company in medical devices and pharmaceuticals focused on respiratory and inhalation, announced the acquisition of Nortev, an Irish company known for producing the equine nebulizer Flexineb. Flexineb is used for respiratory therapy in horses to administer medication or saline via nebulization. Nortev also provides nebulization devices tailored for companion animals.
• On March 23, 2021, PARI Pharma GmbH, a company focused on medical devices and pharmaceuticals announced the authorization of the LAMIRA Nebulizer System in Japan for delivering Insmed's ARIKAYCE (amikacin liposome inhalation suspension). ARIKAYCE received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) following approvals in the U.S. and Europe. LAMIRA marks the first eFlow Technology nebulizer registered for a specific drug outside of Europe and North America.